Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 205-220

  Dluzen, Dean E ^a,b   McDermott, Janet L ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Northeastern Ohio Medical University   (United States)

Author keywords

Brain derived neurotrophic factor (BDNF); Dopamine; Estrogen; Neurodegeneration; Neuroprotection; Parkinson's disease; Sexual differentiation; Testosterone

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESTROGEN; METHAMPHETAMINE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DRUG EFFICACY; FEMALE; FEMINIZATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GONADECTOMY; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NEWBORN PERIOD; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PREPUBERTY; SEX DIFFERENCE; VIRILIZATION;

ANIMALIA;

EID: 10444239345     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1316.026     Document Type: Conference Paper

References (48)

1. HALL, J.N. & P.M. BRODERICK. 1991. Community networks for response to abuse outbreaks of methamphetamine and its analogs. NIDA Res. Monogr. 115: 109-120.
2. ALI, S.F. & T. FREYALDENHOVEN. 1999. MPTP - a model of Parkinson's disease. In Chemicals and Neurodegenerative Disease. S.C. Bondy, Ed.: 161-188. Prominent Press. Scottsdale, AZ.
3. BROOKS, W.J., M.F. JARVIS & G.C. WAGNER. 1989. Influence of sex, age and strain of MPTP-induced neurotoxicity. Res. Commun. Subst. Abuse 10: 181-184.
4. DLUZEN, D.E., C. TWEED, L.I. ANDERSON & N.J. LAPING. 2003. Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system. Neuroendocrinology 77: 232-238.
5. FREYALDENHOVEN, T.E., J.L. CADET & S.F. ALI. 1996. The dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender dependent. Brain Res. 735: 232-238.
6. HELLER, A., N. BUBULA, R. LEW, et al. 2001. Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug. J. Pharmacol. Exp. Ther. 298: 769-779.
7. MILLER, D.B., S.F. ALI, J.P. O'CALLAGHAN & S.C. LAWS. 1998. The impact of gender and estrogen on striatal dopamine neurotoxicity. Ann. N.Y. Acad. Sci. 844: 153-165.
8. WAGNER, G.C., T.L. TEKIRIAN & C.T. CHEO. 1993. Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm. Gen. Sect. 93: 67-70.
9. YU, L. & P.-C. LIAO. 2000. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm. 107: 419-427.
10. YU, Y.-L. & G.C. WAGNER. 1994. Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J. Neural Transm. 8: 215-221.
11. GAO, X. & D.E. DLUZEN. 2001. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Neuroscience 103: 385-394.
12. DLUZEN, D.E. & J.L. MCDERMOTT. 2000. Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system. Ann. N.Y. Acad. Sci. 914: 112-126.
13. DLUZEN, D.E. & J.L. MCDERMOTT. 2002. Estrogen, anti-estrogen, and gender differences in methamphetamine neurotoxicity. Ann. N.Y. Acad. Sci. 965: 136-156.
14. GAJJAR, T.M., L.I. ANDERSON & D.E. DLUZEN. 2003. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J. Neural Transm. 110: 1215-1224.
15. D'ASTOUS, M., M. MORISSETTE, B. TANGUAY, et al. 2003. Dehydroepiandrosterone (DHEA) such as 17β-estradiol prevents MPTP-induced dopamine depletion in mice. Synapse 47: 10-14.
16. DLUZEN, D.E., J.L. MCDERMOTT & B. LIU. 1996. Estrogen alters MPTP-induced neurotoxicity in female mice: effects of striatal dopamine concentrations and release. J. Neurochem. 66: 658-666.
17. DLUZEN, D.E., J.L. MCDERMOTT & B. LIU. 1996. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. Neurotox. Teratol. 18: 603-606.
18. DLUZEN, D.E. 1997. Estrogen decreases corpus striatal neurotoxicity in response to 6-OHDA. Brain Res. 767: 340-344.
19. GRANDBOIS, M., M. MORISSETTE, M. CALLIER & T. DI PAOLO. 2000. Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice. Neuroreport 11: 343-346.
20. TOMAS-CARMARDIEL, M., M.C. SANCHES-HIDALGO, M.J. SANCHEZ DEL PINTO, et al. 2002. Comparative study of the neuroprotective effect of dehyroepiandrosterone and 17β-estradiol against 1-methyl-4-phenylpyridinium toxicity on rat striatum. Neuroscience 109: 569-584.
21. GAO, X. & D.E. DLUZEN. 2001. The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Brain Res. 892: 63-69.
22. YU, L., Y. KUO, C.G. CHENG, et al. 2002. Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum. Neuroendocrinology 75: 282-287.
23. BEYER, C. 1999. Estrogen and the developing brain. Anat. Embryol. 199: 379-390.
24. GORSKI, R.A. 1980. Sexual differentiation of the brain. In Neuroendocrinology. D.T. Kreiger & J.C. Hughes, Eds.: 215-222. Sinauer Associates, Inc. Sunderland, MA.
25. GORSKI, R.A. 1963. Modification of ovulatory mechanisms by postnatal administration of estrogen to the rat. Am. J. Physiol. 205: 842-844.
26. PINILLA, L., M.L. BARREIRO, L.C. GONZALEZ, et al. 2002. Comparative effects of testosterone propionate, oestradiol benzoate, ICI182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat. J. Endocrinol. 172: 441-448.
27. EDWARDS, D.A. 1968. Mice: fighting by neonatally androgenized females. Science 161: 1027-1028.
28. EDWARDS, D.A. 1969. Early androgen stimulation and aggressive behavior in male and female mice. Physiol. Behav. 4: 333-338.
29. EDWARDS, D.A. & K.G. BURGE. 1971. Early androgen treatment and male and female sexual behavior in mice. Horm. Behav. 2: 49-58.
30. BECKER, J. & V.D. RAMIREZ. 1981. Experimental studies on the development of sex differences in the release of dopamine from striatal tissue fragments in vitro. Neuroendocrinology 32: 168-173.
31. CROWLEY, W.R., T.L. O'DONOHUE & D.M. JACOBOWITZ. 1978. Sex differences in catecholamine content in discrete brain nuclei of the rat: effects of neonatal castration or testosterone treatment. Acta Endocrinol. 89: 20-28.
32. LAVIOLA, G., T. PASCUCCI & S. PIERETTI. 2001. Striatal dopamine sensitization to D-amphetamine in periadolescent but not adult rats. Pharm. Biochem. Behav. 68: 115-124.
33. ANDERSEN, S.L., A.P. THOMPSON, E. KRENZEL & M.H. TEICHER. 2002. Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Psychoneuroendocrinology 27: 683-691.
34. ANDERSON, L.I., R.E. LEIPHEIMER & D.E. DLUZEN. 2002. Prepubertal gonadectomy and estrogen neuroprotection of methamphetamine-induced nigrostriatal dopaminergic neurotoxicity. Soc. Neurosci. Abstr. 801.1.
35. ANDERSON, L.I. & D.E. DLUZEN. 2003. Neonatal gonadectomy and estrogen neuroprotection of methamphetamine-induced nigrostriatal dopaminergic neurotoxicity. Soc. Neurosci. Abstr. 535.14.
36. KUPPERS, E. & C. BEYER. 1999. Expression of estrogen receptor-α and βmRNA in the developing and adult mouse striatum. Neurosci. Lett. 276: 95-98.
37. NARITA, M., K. AOKI, M. TAKAGI, et al. 2003. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119: 767-775.
38. MATSUKI, H., Y. SHIRAYAMA, K. HASHIMOTO, et al. 2001. Effects of age and gender on the expression of brain-derived neurotrophic factor mRNA in rat retrosplenial cortex following administration of dizocilpine. Neuropsychopharmacology 25: 258-266.
39. IVANOVA, T., E. KUPPERS, J. ENGELE & C. BEYER. 2001. Estrogen stimulates brain-derived neurotrophic factor expression in embryonic mouse midbrain neurons through a membrane-mediated and calcium-dependent mechanism. J. Neurosci. Res. 66: 221-230.
40. LIU, Y., C.D. FOWLER, L.J. YOUNG, et al. 2001. Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles. J. Comp. Neurol. 433: 499-514.
41. DLUZEN, D.E., G.M. STORY, K. XU, et al. 1999. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp. Neurol. 160: 500-507.
42. DLUZEN, D.E., X. GAO, G.M. STORY, et al. 2001. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp. Neurol. 170: 121-128.
43. DLUZEN, D.E., L.I. ANDERSON, J.L. MCDERMOTT, et al. 2002. Striatal dopamine output is compromised within +/- BDNF mice. Synapse 43: 112-117.
44. BECK, K.D. 1994. Functions of brain-derived neurotrophic factor, insulin-like growth factor and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Prog. Neurobiol. 44: 497-516.
45. HYMAN, C., M. JUHASZ, C. JACKSON, et al. 1994. Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14: 335-347.
46. HOGLINGER, G.U., J. SAUTTER, M. MEYER, et al. 1998. Rat fetal mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function. Brain Res. 813: 313-322.
47. KNUSEL, B., J.W. WINSLOW, A. ROSENTHAL, et al. 1991. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA 88: 961-965.
48. BLOCHL, A. & C. SIRRENBERG. 1996. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75 LNTR receptors. J. Biol. Chem. 271: 21100-21107.